STOCK TITAN

Cadrenal officer Pham proposes 40,000-share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Cadrenal Therapeutics, Inc. (CVKD) officer Quang X. Pham reported a proposed sale of 40,000 common shares, with an aggregate market value of $148,400 and an approximate sale date of June 15, 2026. The notice names Merrill Lynch as broker and lists September 23, 2025, as the adoption date for a Rule 10b5-1 plan. It also reports prior sales between May 11 and June 12, 2026.

Proposed shares to be sold 40,000 common shares Approximate sale date June 15, 2026
Aggregate market value $148,400 Proposed sale
Shares outstanding 2,868,247 shares Number listed in the notice
Rule 10b5-1 plan adoption date September 23, 2025 Proposed sale
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Founders Shares financial
"Nature of Acquisition Transaction: Founders Shares"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CVKD shares does officer Quang X. Pham propose to sell?

Quang X. Pham, an officer of Cadrenal Therapeutics, Inc., proposed selling 40,000 common shares, with an aggregate market value of $148,400. The approximate sale date is June 15, 2026, and Merrill Lynch is named as broker.

When was the Rule 10b5-1 plan for Quang X. Pham's proposed CVKD sale adopted?

The proposed sale is listed with a Rule 10b5-1 plan adopted on September 23, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading